Joseph C L'Huillier, Joseph D Boccardo, Miranda Berkebile, John M Woodward, Jessica L Martinolich, Katia Noyes, Nader D Nader, Csaba Gajdos
{"title":"No Difference in Perioperative Outcomes Following Colorectal Cancer Resection Between Flagship and Non-Flagship Hospitals in New York State.","authors":"Joseph C L'Huillier, Joseph D Boccardo, Miranda Berkebile, John M Woodward, Jessica L Martinolich, Katia Noyes, Nader D Nader, Csaba Gajdos","doi":"10.1002/jso.27949","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hospitals are rapidly consolidating to create large healthcare systems. Whether outcomes following colorectal cancer resection at flagship hospitals differ from those at non-flagship hospitals is unknown.</p><p><strong>Methods: </strong>A 6-year retrospective analysis of an all-payor New York State (NYS) hospital database was conducted. All adult patients with a colorectal resection for primary resectable colorectal cancer were included. Within each system, the hospital with the most colorectal resections was designated the \"flagship\" hospital. Thirty-day outcomes at flagship facilities were compared to affiliated, non-flagship hospitals following colorectal resection while matching for patient-level differences.</p><p><strong>Results: </strong>In total, 28 400 patients were included across 31 healthcare systems in NYS. There were no differences in mortality (0.9% vs. 1.1%), 30-day readmissions (10.5% vs. 11.9%), or postoperative outcomes between matched patients treated at flagship versus non-flagship facilities (p > 0.05).</p><p><strong>Conclusions: </strong>There are no differences in perioperative outcomes between flagship and non-flagship hospitals in a given system in NYS. Patients with resectable non-metastatic colorectal cancer may not need to undergo oncologic resection at flagship hospitals to receive high-quality perioperative care.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jso.27949","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Hospitals are rapidly consolidating to create large healthcare systems. Whether outcomes following colorectal cancer resection at flagship hospitals differ from those at non-flagship hospitals is unknown.
Methods: A 6-year retrospective analysis of an all-payor New York State (NYS) hospital database was conducted. All adult patients with a colorectal resection for primary resectable colorectal cancer were included. Within each system, the hospital with the most colorectal resections was designated the "flagship" hospital. Thirty-day outcomes at flagship facilities were compared to affiliated, non-flagship hospitals following colorectal resection while matching for patient-level differences.
Results: In total, 28 400 patients were included across 31 healthcare systems in NYS. There were no differences in mortality (0.9% vs. 1.1%), 30-day readmissions (10.5% vs. 11.9%), or postoperative outcomes between matched patients treated at flagship versus non-flagship facilities (p > 0.05).
Conclusions: There are no differences in perioperative outcomes between flagship and non-flagship hospitals in a given system in NYS. Patients with resectable non-metastatic colorectal cancer may not need to undergo oncologic resection at flagship hospitals to receive high-quality perioperative care.
期刊介绍:
The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.